tetradecanoylphorbol acetate has been researched along with 1-(1-glycero)dodeca-1,3,5,7,9-pentaene in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Devor, DE; Henneman, JR; Keefer, LK; Logsdon, DL; Rice, JM; Streeter, AJ; Ward, JM | 1 |
Hoshina, S; Morotomi, M; Ueffing, M; Weinstein, IB | 1 |
Farrow, S; Holloway, KA; Howells, L; Kaptein, A; Manson, MM; Munks, RJ; Plummer, SM | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and 1-(1-glycero)dodeca-1,3,5,7,9-pentaene
Article | Year |
---|---|
Carcinogenicity study of fecapentaene-12 diacetate on skin painting in SENCAR mice.
Topics: Adult; Animals; Drug Combinations; Female; Humans; Mice; Mutagens; Papilloma; Polyenes; Skin Neoplasms; Tetradecanoylphorbol Acetate; Vitamin E | 1991 |
Effects of a fecapentaene on protein kinase C.
Topics: Animals; Brain; Calcium; Enzyme Activation; Kinetics; Mutagens; Phosphatidylserines; Polyenes; Protein Kinase C; Rats; Tetradecanoylphorbol Acetate | 1991 |
Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex.
Topics: Antineoplastic Agents; Caffeic Acids; Colonic Neoplasms; Curcumin; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; I-kappa B Kinase; I-kappa B Proteins; Isoenzymes; Membrane Proteins; NF-kappa B; NF-kappaB-Inducing Kinase; Phenylethyl Alcohol; Polyenes; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1999 |